Immunotherapy

Immunotherapy

1750-743X

1750-7448

Therapeutic Area

Allergy, Health Economics/Outcomes Research, Immunology, Internal Medicine, Molecular Medicine, Nuclear Medicine, Oncology, Pharmaceutical Technology/Drug Technology, Pharmacoeconomics, Pharmacovigilence, Radiology, Sexual Health, Transplantation, Vaccines/Vaccinology

Allergists, Bioengineers, Biomedical Engineers/Technologists, Biomedical Researchers, Clinicians, Health Scientists, Immunologists, Molecular Biologists, Nuclear Medicine Physicians, Oncologists, Outcomes Manager, Pharmaceutical Scientistists, Pharmaco-Epidemiologists, Pharmacologists, Pharmacovigilence Specialists, Researchers, Scientists

Immunotherapy is a subscription-based peer-reviewed journal covering both preclinical research and clinical research, as well as the applications of immunotherapy. The journal’s audience includes researchers and clinicians interested in immunotherapy for cancers and other diseases. Journal coverage includes key areas such as: Cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies and cytokines; Combined chemo/radio immunotherapy in cancer treatment; Biomarkers for personalized cancer immunotherapy; Allergen immunotherapy, including sublingual, subcutaneous and oral immunotherapy; Restorative immunotherapy for HIV and other immunocompromised patients; Suppressive immunotherapy for autoimmunity diseases and transplantation; Basic science of immunotherapeutic approaches; Drug–immune system interactions; Drug delivery systems, drug combinations and drug–drug interactions; Summaries evaluating newly approved immunotherapeutic agents; Newly identified immune targets of drugs; Results of recent findings and clinical trials relevant to the field of immunotherapy; Post marketing research, including adverse events, drug safety, pharmacoeconomics, cost–benefit issues, real-world evidence and outcomes research. The journal welcomes for consideration the following: Case Reports/Series, Clinical Trial Protocols, Drug Evaluations, Editorials, Plain Language Summaries, Original Research Articles, Reviews. All articles received by the journal will be subject to double-anonymous peer review.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Frequency Journal Contact Author Submission Guidelines